Prof. Dr. Thomas Herget
CEO
Scientist and innovation executive who recently led the global innovation network of Merck KGaA.
He holds a doctorate in genetics and a habilitation in physiological chemistry, and is an inventor, author, and award-winning expert in cell biology, bioelectronics, and cultured meat.
Prof. Dr.-Ing. Andreas Blaeser
Hardware
Professor and Chair of BioMedical Printing Technology, specializing in 3D bioprinting systems for regenerative medicine and organ-on-a-chip applications. His research focuses on biomaterial transport, cell interactions, and scalable biofabrication technologies for clinical and industrial use
Robin Maatz
CTO
Research focuses on scalable screen-printing technologies for structured cultivated meat production. The work combines bioink development, 3D hydrogel printing, and bioreactor cultivation to enable cost-efficient industrial manufacturing of in vitro meat products.
Michael Schaberger
Commercial
Supports the venture in an advisory and investor role, contributing extensive experience in new business building, venturing, and corporate development. At Merck KGaA, he served as Commerical Managing Director for multiple commercialization initiatives within the Innovation Center. He holds academic backgrounds in law and business